|
1
|
Calle MC and Fernandez ML: Inflammation
and type 2 diabetes. Diabetes Metab. 38:183–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prattichizzo F, De Nigris V, La Sala L,
Procopio AD, Olivieri F and Ceriello A: ‘Inflammaging’ as a
druggable target: A senescence-associated secretory
phenotype-centered view of type 2 diabetes. Oxid Med Cell Longev.
2016:18103272016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esser N, Legrand-Poels S, Piette J, Scheen
AJ and Paquot N: Inflammation as a link between obesity, metabolic
syndrome and type 2 diabetes. Diabetes Res Clin Pract. 105:141–150.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Assar ME, Angulo J and Rodriguez-Manas L:
Diabetes and ageing-induced vascular inflammation. J Physiol.
594:2125–2146. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bessueille L and Magne D: Inflammation: A
culprit for vascular calcification in atherosclerosis and diabetes.
Cell Mol Life Sci. 72:2475–2489. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelsey MM, Forster JE, Van Pelt RE, Reusch
JE and Nadeau KJ: Adipose tissue insulin resistance in adolescents
with and without type 2 diabetes. Pediatr Obes. 9:373–380. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee J: Adipose tissue macrophages in the
development of obesity-induced inflammation, insulin resistance and
type 2 diabetes. Arch Pharm Res. 36:208–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Silaghi CA, Silaghi H, Crăciun AE, Fărcaș
A, Colosi HA, Cosma DT, Pais R, Hâncu N and Georgescu CE: Age,
abdominal obesity, and glycated hemoglobin are associated with
carotid atherosclerosis in type 2 diabetes patients with
nonalcoholic fatty liver disease. Med Ultrason. 17:300–307. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jung CH, Kim BY, Kim KJ, Jung SH, Kim CH,
Kang SK and Mok JO: Contribution of subcutaneous abdominal fat on
ultrasonography to carotid atherosclerosis in patients with type 2
diabetes mellitus. Cardiovasc Diabetol. 13:672014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McGown C, Birerdinc A and Younossi ZM:
Adipose tissue as an endocrine organ. Clinics Liver Dis. 18:41–58.
2014. View Article : Google Scholar
|
|
11
|
Coelho M, Oliveira T and Fernandes R:
Biochemistry of adipose tissue: An endocrine organ. Arch Med Sci.
9:191–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adamczak M and Wiecek A: The adipose
tissue as an endocrine organ. Semin Nephrol. 33:2–13. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin Z, Deng T, Peterson LE, Yu R, Lin J,
Hamilton DJ, Reardon PR, Sherman V, Winnier GE, Zhan M, et al:
Transcriptome analysis of human adipocytes implicates the NOD-like
receptor pathway in obesity-induced adipose inflammation. Mol Cell
Endocrinol. 394:80–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kursawe R, Dixit VD, Scherer PE, Santoro
N, Narayan D, Gordillo R, Giannini C, Lopez X, Pierpont B, Nouws J,
et al: A role of the inflammasome in the low storage capacity of
the abdominal subcutaneous adipose tissue in obese adolescents.
Diabetes. 65:610–618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murphy AM, Lyons CL, Finucane OM and Roche
HM: Interactions between differential fatty acids and inflammatory
stressors-impact on metabolic health. Prostaglandins Leukot Essent
Fatty Acids. 92:49–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bando S, Fukuda D, Soeki T, Nishimoto S,
Uematsu E, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, et
al: Expression of NLRP3 in subcutaneous adipose tissue is
associated with coronary atherosclerosis. Atherosclerosis.
242:407–414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Renga B: Hydrogen sulfide generation in
mammals: The molecular biology of cystathionine-β-synthase (CBS)
and cystathionine-gamma-lyase (CSE). Inflamm Allergy Drug Targets.
10:85–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tripatara P, Patel NS, Collino M,
Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown
PA, Yaqoob MM, et al: Generation of endogenous hydrogen sulfide by
cystathionine gamma-lyase limits renal ischemia/reperfusion injury
and dysfunction. Lab Invest. 88:1038–1048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Panthi S, Chung HJ, Jung J and Jeong NY:
Physiological importance of hydrogen sulfide: Emerging potent
neuroprotector and neuromodulator. Oxid Med Cell Longev.
2016:90497822016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng XM, Huang X, Zhang CM, Liu DH, Lu HL,
Kim YC and Xu WX: Hydrogen sulfide-induced enhancement of gastric
fundus smooth muscle tone is mediated by voltage-dependent
potassium and calcium channels in mice. World J Gastroenterol.
21:4840–4851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Das A, Samidurai A, Hoke NN, Kukreja RC
and Salloum FN: Hydrogen sulfide mediates the cardioprotective
effects of gene therapy with PKG-Iα. Basic Res Cardiol. 110:422015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vandiver M and Snyder SH: Hydrogen
sulfide: A gasotransmitter of clinical relevance. J Mol Med (Berl).
90:255–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang XH, Wang F, You SJ, Cao YJ, Cao LD,
Han Q, Liu CF and Hu LF: Dysregulation of cystathionine γ-lyase
(CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced
inflammation in macrophage. Cell Signal. 25:2255–2262. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hirata I, Naito Y, Takagi T, Mizushima K,
Suzuki T, Omatsu T, Handa O, Ichikawa H, Ueda H and Yoshikawa T:
Endogenous hydrogen sulfide is an anti-inflammatory molecule in
dextran sodium sulfate-induced colitis in mice. Dig Dis Sci.
56:1379–1386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu XH, Cui LB, Wu K, Zheng XL, Cayabyab
FS, Chen ZW and Tang CK: Hydrogen sulfide as a potent
cardiovascular protective agent. Clin Chim Acta. 437:78–87. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu S, Liu Z and Liu P: Targeting hydrogen
sulfide as a promising therapeutic strategy for atherosclerosis.
Int J Cardiol. 172:313–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsai CY, Peh MT, Feng W, Dymock BW and
Moore PK: Hydrogen sulfide promotes adipogenesis in 3T3L1 cells.
PKLoS One. 10:e01195112015. View Article : Google Scholar
|
|
28
|
Beltowski J: Endogenous hydrogen sulfide
in perivascular adipose tissue: Role in the regulation of vascular
tone in physiology and pathology. Can J Physiol Pharmacol.
91:889–898. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan Z, Wang H, Liu Y, Yu C, Zhang Y, Chen
J, Wang X and Guan Q: Involvement of CSE/H2S in high glucose
induced aberrant secretion of adipokines in 3T3-L1 adipocytes.
Lipids Health Dis. 13:1552014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu TX, Wang G, Wu W, Gao L, Tan QY and
Wang J: Hydrogen sulfide inhibits high glucose-induced sFlt-1
production via decreasing ADAM17 expression in 3T3-L1 adipocytes.
Int J Endocrinol. 2017:95017922017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grosick R, Alvarado-Vazquez PA,
Messersmith AR and Romero-Sandoval EA: High glucose induces a
priming effect in macrophages and exacerbates the production of
pro-inflammatory cytokines after a challenge. J Pain Res.
11:1769–1778. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Briones L, Andrews M, Pizarro F and
Arredondo-Olguin M: Expression of genes associated with
inflammation and iron metabolism in 3T3-L1 cells induced with
macrophages-conditioned medium, glucose and iron. Biometals.
31:595–604. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Akbarzadeh M, Eftekhari MH, Dabbaghmanesh
MH, Hasanzadeh J and Bakhshayeshkaram M: Serum IL-18 and hsCRP
correlate with insulin resistance without effect of calcitriol
treatment on type 2 diabetes. Iran J Immunol. 10:167–176.
2013.PubMed/NCBI
|
|
34
|
Mir M, Rostami A and Hormozi M: Comparison
of serum levels of IL-18 in peripheral blood of patients with type
II diabetes with nephropathy clinical protests and patients with
type II diabetes without nephropathy clinical protests. Diabetes
Metab Syndr. 11:245–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herder C, Dalmas E, Boni-Schnetzler M and
Donath MY: The IL-1 pathway in type 2 diabetes and cardiovascular
complications. Trends Endocrinol Metab. 26:551–563. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Banerjee M and Saxena M: Interleukin-1
(IL-1) family of cytokines: Role in type 2 diabetes. Clin Chim
Acta. 413:1163–1170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Daniele G, Guardado Mendoza R, Winnier D,
Fiorentino TV, Pengou Z, Cornell J, Andreozzi F, Jenkinson C,
Cersosimo E, Federici M, et al: The inflammatory status score
including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and
adiponectin underlies whole-body insulin resistance and
hyperglycemia in type 2 diabetes mellitus. Acta Diabetol.
51:123–131. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hussain G, Rizvi SA, Singhal S, Zubair M
and Ahmad J: Serum levels of TNF-α in peripheral neuropathy
patients and its correlation with nerve conduction velocity in type
2 diabetes mellitus. Diabetes Metab Syndr. 7:238–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hardaway AL and Podgorski I: IL-1β, RAGE
and FABP4: Targeting the dynamic trio in metabolic inflammation and
related pathologies. Future Med Chem. 5:1089–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dinarello CA: Interleukin-18 and the
pathogenesis of inflammatory diseases. Semin Nephrol. 27:98–114.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee CC, Lorenzo C, Haffner SM, Wagenknecht
LE, Festa A, Goodarzi MO, Stefanovski D, Olson NC, Norris JM,
Rewers MJ and Hanley AJ: The association of inflammatory and
fibrinolytic proteins with 5 year change in insulin clearance: The
Insulin resistance atherosclerosis study (IRAS). Diabetologia.
56:112–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Maedler K, Dharmadhikari G, Schumann DM
and Storling J: Interleukin-1 beta targeted therapy for type 2
diabetes. Expert Opin Biol Ther. 9:1177–1188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bosch M, Lopez-Bermejo A, Vendrell J,
Musri M, Ricart W and Fernandez-Real JM: Circulating IL-18
concentration is associated with insulin sensitivity and glucose
tolerance through increased fat-free mass. Diabetologia.
48:1841–1843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Frostegard J: Immune mechanisms in
atherosclerosis, especially in diabetes type 2. Front Endocrinol
(Lausanne). 4:1622013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vandanmagsar B, Youm YH, Ravussin A,
Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM and Dixit
VD: The NLRP3 inflammasome instigates obesity-induced inflammation
and insulin resistance. Nat Med. 17:179–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Esser N, L'Homme L, De Roover A, Kohnen L,
Scheen AJ, Moutschen M, Piette J, Legrand-Poels S and Paquot N:
Obesity phenotype is related to NLRP3 inflammasome activity and
immunological profile of visceral adipose tissue. Diabetologia.
56:2487–2497. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zilverschoon GR, Tack CJ, Joosten LA,
Kullberg BJ, van der Meer JW and Netea MG: Interleukin-18
resistance in patients with obesity and type 2 diabetes mellitus.
Int J Obes (Lond). 32:1407–1414. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Feng X, Chen Y, Zhao J, Tang C, Jiang Z
and Geng B: Hydrogen sulfide from adipose tissue is a novel insulin
resistance regulator. Biochem Biophys Res Commun. 380:153–159.
2009. View Article : Google Scholar : PubMed/NCBI
|
